BusinessLEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Katanga Mining Limited To Contact The FirmBy Nasdaq OMXNov 30, 2017, 8:19 PM UTC
BusinessSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Triangle Capital Corporation (NYSE: TCAP) To Contact Brower Piven Before The Lead Plaintiff DeadlineBy Nasdaq OMXNov 30, 2017, 7:50 PM UTC
BusinessSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In RYB Education, Inc. (NYSE: RYB) To Contact Brower Piven Before The Lead Plaintiff DeadlineBy Nasdaq OMXNov 30, 2017, 7:39 PM UTC
BusinessSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Tivity Health, Inc. (NASDAQ: TVTY) To Contact Brower Piven Before The Lead Plaintiff DeadlineBy Nasdaq OMXNov 30, 2017, 7:39 PM UTC
BusinessSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Katanga Mining Limited (Other OTC: KATFF) To Contact Brower Piven Before The Lead Plaintiff DeadlineBy Nasdaq OMXNov 30, 2017, 7:28 PM UTC
BusinessSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Alkermes plc (Nasdaq: ALKS) To Contact Brower Piven Before The Lead Plaintiff DeadlineBy Nasdaq OMXNov 30, 2017, 7:26 PM UTC
BusinessSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Array BioPharma Inc. (Nasdaq: ARRY) To Contact Brower Piven Before The Lead Plaintiff DeadlineBy Nasdaq OMXNov 30, 2017, 7:25 PM UTC
BusinessSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Acorda Therapeutics, Inc. (Nasdaq: ACOR) To Contact Brower Piven Before The Lead Plaintiff DeadlineBy Nasdaq OMXNov 30, 2017, 7:23 PM UTC
